• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CARDIOVASCULAR SYSTEMS CORPORATION STERILE FX25REC W/RES; BLOOD GAS OXYGENATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CARDIOVASCULAR SYSTEMS CORPORATION STERILE FX25REC W/RES; BLOOD GAS OXYGENATOR Back to Search Results
Model Number 3CX*FX25REC
Device Problem Use of Device Problem (1670)
Patient Problem Blood Loss (2597)
Event Date 07/21/2017
Event Type  Injury  
Manufacturer Narrative
The actual sample was not returned to the factory for evaluation.The retention sample of the involved product and lot number was verified to be normal product.Visual inspection did not find any anomaly, such as break in the appearance.The retention sample was tested for its gas transfer performance in accordance to the factory's shipping inspection and no anomalies were revealed.Root cause could not be identified, however, there may have been some physiological factors contributing to the event.(b)(4).Method codes: device from reserve sample evaluated.Visual inspection.Flow testing.Results code: no failure detected.Conclusions codes: unable to confirm complaint.Device not returned.All available information has been placed on file in quality management for appropriate tracking, trending and follow-up.
 
Event Description
The user facility reported to terumo cardiovascular that during cardiopulmonary bypass (cpb), the oxygenator had a gas exchange failure.Serious injury was noted.Product was not changed out.Surgery was not completed successfully.A whitish milky layer on top of the layer of blood was noticed when it was sitting idle in the chamber of the cardioplegia device.They had problems oxygenating the patient in the intensive care unit ( icu) so they tried nitric oxide therapy but it did not help.The patient had been stable from a cardiac perspective but then went into full blown congestive heart failure and pulmonary edema in the icu post-operatively and they could not ventilate him so he was taken back to the operating room (or).Patient had fluid coming out of the endotracheal tub; estimated that they sucked out about two liters of fluid out of the patient's lungs.Patient was put back on cpb while waiting for a different facility's team to arrive to put the patient on ecmo.The patient was placed on cpb with an fx25rec, patient oxygenation improved, but lactate levels were higher than measurable.The po2 values steadily decreased and the pco2 values increased over time from 2200 to 0140.At 0140 the po2 and pco2 were in the 50s so they partially filled up the heart and had anesthesia start ventilating to help oxygenate the patient.The po2 increased to 73 at 0155.Once the patient was placed on the ecmo circuit, gas exchange significantly improved with the po2 in the 400s and pco2 in the mid 30s.Clinician indicated there may have been some protein/platelet activation occurring which was clogging the fibers in the oxygenator resulting in the decline in gas exchange performance.The fiber bundle was clean (no fibrin or clot on the fibers) when the blood was sent cell saver.Act values were >1000 most of the time; the last act before the patient was transported was 635 when on ecmo.Approximately 24 hours after the patient was transferred for ecmo, the patient was still on the original ecmo circuit.The patient's creatinine was extremely high and the patient was in renal failure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STERILE FX25REC W/RES
Type of Device
BLOOD GAS OXYGENATOR
Manufacturer (Section D)
TERUMO CARDIOVASCULAR SYSTEMS CORPORATION
125 blue ball road
elkton MD 21921
Manufacturer Contact
cathleen hargreaves
125 blue ball road
elkton, MD 21921
8002837866
MDR Report Key6870669
MDR Text Key86426079
Report Number1124841-2017-00191
Device Sequence Number1
Product Code DTZ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K153213
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Other
Type of Report Initial
Report Date 09/15/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/30/2020
Device Model Number3CX*FX25REC
Device Catalogue NumberN/A
Device Lot NumberVF22
Other Device ID Number(01)00699753450820
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 09/06/2017
Initial Date FDA Received09/15/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/24/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-